HHS chief invokes authority to force rejection of broad Plan B OTC sales
This article was originally published in Scrip
Executive Summary
In what may have been a "good cop, bad cop" move to get around a controversial issue in the coming election year, Health and Human Services (HHS) Secretary Kathleen Sebelius invoked her federal authority to overrule a decision by FDA Commissioner Margaret Hamburg to allow Teva to market its emergency contraceptive Plan B One-Step (1.5 mg levonorgestrel tablet) without a prescription to all girls and women.